The prevention or treatment of disease with substances that stimulate the immune response.
We aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.
Case numbers are resurging in parts of the world where the COVID-19 pandemic was waning, falling in places that saw huge surges recently, and just beginning to rise in previously little-impacted parts of the globe.
Studying and analyzing the impact of Coronavirus COVID-19 on the Immunotherapy industry, the report provide in-depth analysis and professtional advices on how to face the post COIVD-19 period.
Market Segment by Product Type
Monotherapy
Combination Therapy
Market Segment by Product Application
Hematologic Malignancies
Solid Malignancies
Finally, the report provides detailed profile and data information analysis of leading company.
AbbVie
Celgene
Kite Pharma
Oxford BioMedica
Novartis
Gilead
Pfizer
Cellectis
Bellicum
Mustang Bio
CARsgen Therapeutics
Xyphos
Minerva Biotechnologies
Adaptimmune
Ziopharm Oncology
Aurora Biopharma
Creative Biolabs
Insights and Tools:
Projected and forecast revenue values are in constant U.S. dollars, unadjusted for inflation.
Product values and regional markets are estimated by market analyst, data analyst and people from related industry, based on companys' revenue and applications market respectively.
The data sources include but not limited to reports of companys,international organizations and governments, MMI market surveys,and related industry news.
Analyses of global market trends, with historical data, estimates for 2022 and projections of compound annual growth rates (CAGRs) through 2027
The market research includes historical and forecast data from like demand, application details, price trends, and company shares by geography, especially focuses on the key regions like United States, European Union, China, and other regions.
In addition, the report provides insight into main drivers,challenges,opportunities and risk of the market and strategies of suppliers. Key players are profiled as well with their market shares in the global market discussed.
Research Objectives
1.To study and analyze the global Immunotherapy consumption (value) by key regions/countries, product type and application, history data from 2017 to 2021, and forecast to 2027.
2.To understand the structure of Immunotherapy market by identifying its various subsegments.
3.Focuses on the key global Immunotherapy manufacturers, to define, describe and analyze the value, market share, market competition landscape, Porter's five forces analysis, SWOT analysis and development plans in next few years.
4.To analyze the Immunotherapy with respect to individual growth trends, future prospects, and their contribution to the total market.
5.To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
6.To project the consumption of Immunotherapy submarkets, with respect to key regions (along with their respective key countries).
7.To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
8.To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
Global Immunotherapy Market Research Report 2022, Forecast to 2027
1 Market Study Overview
1.1 Study Objectives
1.2 Immunotherapy Introduce
1.3 Combined with the Analysis of Macroeconomic Indicators
1.4 Brief Description of Research methods
1.5 Market Breakdown and Data Triangulation
2 Global Trend Summary
2.1 Immunotherapy Segment by Type
2.1.1 Monotherapy
2.1.2 Combination Therapy
2.2 Market Analysis by Application
2.2.1 Hematologic Malignancies
2.2.2 Solid Malignancies
2.3 Global Immunotherapy Market Comparison by Regions (2017-2027)
2.3.1 Global Immunotherapy Market Size (2017-2027)
2.3.2 North America Immunotherapy Status and Prospect (2017-2027)
2.3.3 Europe Immunotherapy Status and Prospect (2017-2027)
2.3.4 China Immunotherapy Status and Prospect (2017-2027)
2.3.5 Japan Immunotherapy Status and Prospect (2017-2027)
2.3.6 Southeast Asia Immunotherapy Status and Prospect (2017-2027)
2.4 Basic Product Information
2.4.1 Basic Product Information & Technology Development History
2.4.2 Product Manufacturing Process
2.4.3 Interview with Major Market Participants
2.4.4 High-end Market Analysis and Forecast
2.5 Coronavirus Disease 2019 (Covid-19): Immunotherapy Industry Impact
2.5.1 Immunotherapy Business Impact Assessment - Covid-19
2.5.2 Market Trends and Immunotherapy Potential Opportunities in the COVID-19 Landscape
2.5.3 Measures / Proposal against Covid-19
3 Competition by Manufacturer
3.1 Global Immunotherapy Sales and Market Share by Manufacturer (2017-2022)
3.2 Global Immunotherapy Revenue and Market Share by Manufacturer (2017-2022)
3.3 Global Immunotherapy Industry Concentration Ratio (CR5 and HHI)
3.4 Top 5 Immunotherapy Manufacturer Market Share
3.5 Top 10 Immunotherapy Manufacturer Market Share
3.6 Date of Key Manufacturers Enter into Immunotherapy Market
3.7 Key Manufacturers Immunotherapy Key Manufacturers
3.8 Mergers & Acquisitions Planning
4 Analysis of Immunotherapy Industry Key Manufacturers
4.1 AbbVie
4.1.1 Compan Detail
4.1.2 AbbVie Immunotherapy Product Introduction, Application and Specification
4.1.3 AbbVie 162 Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.1.4 Main Business Overview
4.1.5 AbbVie News
4.2 Celgene
4.2.1 Compan Detail
4.2.2 Celgene Immunotherapy Product Introduction, Application and Specification
4.2.3 Celgene Immunotherapy Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.2.4 Main Business Overview
4.2.5 AbbVie News
4.3 Kite Pharma
4.3.1 Compan Detail
4.3.2 Kite Pharma Immunotherapy Product Introduction, Application and Specification
4.3.3 Kite Pharma Immunotherapy Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.3.4 Main Business Overview
4.3.5 Kite Pharma News
4.4 Oxford BioMedica
4.4.1 Compan Detail
4.4.2 Oxford BioMedica Immunotherapy Product Introduction, Application and Specification
4.4.3 Oxford BioMedica Immunotherapy Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.4.4 Main Business Overview
4.4.5 Oxford BioMedica News
4.5 Novartis
4.5.1 Compan Detail
4.5.2 Oxford BioMedica Immunotherapy Product Introduction, Application and Specification
4.5.3 Novartis Immunotherapy Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.5.4 Main Business Overview
4.5.5 Novartis News
4.6 Gilead
4.6.1 Compan Detail
4.6.2 Gilead Immunotherapy Product Introduction, Application and Specification
4.6.3 Gilead Immunotherapy Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.6.4 Main Business Overview
4.6.5 Gilead News
4.7 Pfizer
4.7.1 Compan Detail
4.7.2 Pfizer Immunotherapy Product Introduction, Application and Specification
4.7.3 Pfizer Immunotherapy Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.7.4 Main Business Overview
4.7.4 Main Business Overview
4.8 Cellectis
4.8.1 Compan Detail
4.8.2 Cellectis Immunotherapy Product Introduction, Application and Specification
4.8.3 Cellectis Immunotherapy Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.8.4 Main Business Overview
4.8.5 Cellectis News
4.9 Bellicum
4.9.1 Compan Detail
4.9.2 Bellicum Immunotherapy Product Introduction, Application and Specification
4.9.3 Bellicum Immunotherapy Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.9.4 Main Business Overview
4.9.5 Bellicum News
4.10 Mustang Bio
4.10.1 Compan Detail
4.10.2 Mustang Bio Immunotherapy Product Introduction, Application and Specification
4.10.3 Mustang Bio Immunotherapy Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.10.4 Main Business Overview
4.10.5 Mustang Bio News
4.11 CARsgen Therapeutics
4.11.1 Compan Detail
4.11.2 CARsgen Therapeutics Immunotherapy Product Introduction, Application and Specification
4.11.3 CARsgen Therapeutics Immunotherapy Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.11.4 Main Business Overview
4.11.5 CARsgen Therapeutics News
4.12 Xyphos
4.12.1 Compan Detail
4.12.2 Xyphos Immunotherapy Product Introduction, Application and Specification
4.12.3 Xyphos Immunotherapy Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.12.4 Main Business Overview
4.12.5 Xyphos News
4.13 Minerva Biotechnologies
4.13.1 Company Details
4.13.2 Minerva Biotechnologies Immunotherapy Product Introduction, Application and Specification
4.13.3 Minerva Biotechnologies Immunotherapy Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.13.4 Main Business Overview
4.13.5 Minerva Biotechnologies News
4.14 Adaptimmune
4.14.1 Compan Detail
4.14.2 Adaptimmune Immunotherapy Product Introduction, Application and Specification
4.14.3 Adaptimmune Immunotherapy Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.14.4 Main Business Overview
4.14.5 Adaptimmune News
4.15 Ziopharm Oncology
4.15.1 Compan Detail
4.15.2 Ziopharm Oncology Immunotherapy Product Introduction, Application and Specification
4.15.3 Ziopharm Oncology Immunotherapy Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.15.4 Main Business Overview
4.15.5 Ziopharm Oncology News
4.16 Aurora Biopharma
4.16.1 Compan Detail
4.16.2 Aurora Biopharma Immunotherapy Product Introduction, Application and Specification
4.16.3 Aurora Biopharma Immunotherapy Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.16.4 Main Business Overview
4.16.5 Aurora Biopharma News
4.17 Creative Biolabs
4.17.1 Compan Detail
4.17.2 Creative Biolabs Immunotherapy Product Introduction, Application and Specification
4.17.3 Creative Biolabs Immunotherapy Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.17.4 Main Business Overview
4.17.5 Creative Biolabs News
4.18.1 Compan Detail
5 Global Immunotherapy Market Segment by Big Type
5.1 Global Immunotherapy Revenue, Sales and Market Share by Big Type (2017-2022)
5.1.1 Global Immunotherapy Sales and Market Share by Big Type (2017-2022)
5.1.2 Global Immunotherapy Revenue and Market Share by Big Type (2017-2022)
5.2 Monotherapy Sales Growth Rate and Price
5.2.1 Global Monotherapy Sales Growth Rate (2017-2022)
5.2.2 Global Monotherapy Price (2017-2022)
5.3 Combination Therapy Sales Growth Rate and Price
5.3.1 Global Combination Therapy Sales Growth Rate (2017-2022)
5.3.2 Global Combination Therapy Price (2017-2022)
6 Global Immunotherapy Market Segment by Big Application
6.1 Global Immunotherapy Sales Market Share by Big Application (2017-2022)
6.2 Hematologic Malignancies Sales Growth Rate (2017-2022)
6.3 Solid Malignancies Sales Growth Rate (2017-2022)
7 Global Immunotherapy Forecast
7.1 Global Immunotherapy Revenue, Sales and Growth Rate (2022-2027)
7.2 Immunotherapy Market Forecast by Regions (2022-2027)
7.2.1 North America Immunotherapy Market Forecast (2022-2027)
7.2.2 Europe Immunotherapy Market Forecast (2022-2027)
7.2.3 China Immunotherapy Market Forecast (2022-2027)
7.2.4 Japan Immunotherapy Market Forecast (2022-2027)
7.2.5 Southeast Asia Immunotherapy Market Forecast (2022-2027)
7.2.6 Other Regions Immunotherapy Market Forecast (2022-2027)
7.3 Immunotherapy Market Forecast by Type (2022-2027)
7.3.1 Global Immunotherapy Sales Forecast by Type (2022-2027)
7.3.2 Global Immunotherapy Market Share Forecast by Type (2022-2027)
7.4 Immunotherapy Market Forecast by Application (2022-2027)
7.4.1 Global Immunotherapy Sales Forecast by Application (2022-2027)
7.4.2 Global Immunotherapy Market Share Forecast by Application (2022-2027)
8 Market Analysis
8.1.1 Market Overview
8.1.2 Market Opportunities
8.1.3 Market Risk
8.1.4 Market Driving Force
8.1.5 Porter's Five Forces Analysis
8.1.6 SWOT Analysis
9 Immunotherapy Related Market Analysis
9.1 Upstream Analysis
9.1.1 Macro Analysis of Upstream Markets
9.1.2 Key Players in Upstream Markets
9.1.3 Upstream Market Trend Analysis
9.1.4 Immunotherapy Manufacturing Cost Analysis
9.2 Downstream Market Analysis
9.2.1 Macro Analysis of Down Markets
9.2.2 Key Players in Down Markets
9.2.3 Downstream Market Trend Analysis
9.2.4 Sales Channel, Distributors, Traders and Dealers
10 Research Findings and Conclusion
List of Tables and Figures
Figure Product Picture Immunotherapy
Figure Market Concentration Ratio and Market Maturity Analysis of Immunotherapy
Figure Bottom-up and Top-down Approaches for This Report
Figure Part of Our External Database
Figure Part of Our External Database
Figure Key Executives Interviewed
Table Global Immunotherapy Market Size by Big Type
Figure Global Market Share of Immunotherapy by Big Type in 2021
Figure Monotherapy Picture (2017-2022)
Global Immunotherapy Market Size by Big Application
Table Global Immunotherapy Market Size by Application
Figure Global Immunotherapy Market Share by Big Application in 2021
Figure Hematologic Malignancies Picture
Figure Solid Malignancies Picture
Table Global Immunotherapy Comparison by Regions (M USD) (2017-2027)
Figure Global Immunotherapy Market Size (Million US$) (2017-2027)
Figure North America Immunotherapy Revenue (Million US$) Growth Rate (2017-2027)
Figure Europe Immunotherapy Revenue (Million US$) Growth Rate (2017-2027)
Figure China Immunotherapy Revenue (Million US$) Growth Rate (2017-2027)
Figure Japan Immunotherapy Revenue (Million US$) Growth Rate (2017-2027)
Figure Southeast Asia Immunotherapy Revenue (Million US$) Growth Rate (2017-2027)
Table Business Impact Assessment - Covid-19
Table Market Trends and Immunotherapy Potential Opportunities in the COVID-19 Landscape
Table Measures / Proposal against Covid-19
Table Global Immunotherapy Sales by Manufacturer (2017-2022)
Figure Global Immunotherapy Sales Market Share by Manufacturer in 2021
Table Global Immunotherapy Revenue by Manufacturer (2017-2022)
Figure Global Immunotherapy Revenue Market Share by Manufacturer in 2021
Table Global Immunotherapy Manufacturers Market Concentration Ratio (CR5 and HHI)
Figure Top 5 Immunotherapy Manufacturer (Revenue) Market Share in 2021
Figure Top 10 Immunotherapy Manufacturer (Revenue) Market Share in 2021
Table Date of Key Manufacturers Enter into Immunotherapy Market
Table Key Manufacturers Immunotherapy Product Type
Table Mergers & Acquisitions Planning
Table AbbVie Company Profile
Table Immunotherapy Product Introduction, Application and Specification of AbbVie
Table Immunotherapy Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company One 2017-2022
Table Company One Main Business
Table Company One Recent Development
Table Celgene Company Profile
Table Immunotherapy Product Introduction, Application and Specification of Celgene
Table Immunotherapy Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Celgene Recent Development
Table Kite Pharma Company Profile
Table Immunotherapy Product Introduction, Application and Specification of Kite Pharma
Table Immunotherapy Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Kite Pharma Main Business
Table Kite Pharma Recent Development
Table Oxford BioMedica Company Profile
Table Immunotherapy Product Introduction, Application and Specification of Oxford BioMedica
Table Immunotherapy Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Oxford BioMedica Main Business
Table Oxford BioMedica Recent Development
Table Oxford BioMedica Main Business
Table Oxford BioMedica Recent Development
Table Novartis Company Profile
Table Immunotherapy Product Introduction, Application and Specification of Novartis
Table Immunotherapy Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Novartis Main Business
Table Novartis Recent Development
Table Gilead Company Profile
Table Immunotherapy Product Introduction, Application and Specification of Gilead
Table Immunotherapy Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Gilead Main Business
Table Gilead Recent Development
Table Pfizer Company Profile
Table Immunotherapy Product Introduction, Application and Specification of Pfizer
Table Immunotherapy Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Pfizer Main Business
Table Pfizer Recent Development
Table Cellectis Company Profile
Table Immunotherapy Product Introduction, Application and Specification of Cellectis
Table Immunotherapy Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Cellectis Main Business
Table Cellectis Recent Development
Table Bellicum Company Profile
Table Immunotherapy Product Introduction, Application and Specification of Bellicum
Table Immunotherapy Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Bellicum Main Business
Table Bellicum Recent Development
Table Mustang Bio Company Profile
Table Immunotherapy Product Introduction, Application and Specification of Mustang Bio
Table Immunotherapy Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Mustang Bio Main Business
Table Mustang Bio Recent Development
Table CARsgen Therapeutics Company Profile
Table Immunotherapy Product Introduction, Application and Specification of CARsgen Therapeutics
Table Immunotherapy Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table CARsgen Therapeutics Main Business
Table CARsgen Therapeutics Recent Development
Table Xyphos Company Profile
Table Immunotherapy Product Introduction, Application and Specification of Xyphos
Table Immunotherapy Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Xyphos Main Business
Table Xyphos Recent Development
Table Minerva Biotechnologies Company Profile
Table Immunotherapy Product Introduction, Application and Specification of Minerva Biotechnologies
Table Immunotherapy Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Minerva Biotechnologies Main Business
Table Minerva Biotechnologies Recent Development
Table Adaptimmune Company Profile
Table Immunotherapy Product Introduction, Application and Specification of Adaptimmune
Table Immunotherapy Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Adaptimmune Main Business
Table Adaptimmune Recent Development
Table Aurora Biopharma Company Profile
Table Immunotherapy Product Introduction, Application and Specification of Aurora Biopharma
Table Immunotherapy Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Aurora Biopharma Main Business
Table Aurora Biopharma Recent Development
Table Creative Biolabs Company Profile
Table Immunotherapy Product Introduction, Application and Specification of Creative Biolabs
Table Immunotherapy Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Creative Biolabs Main Business
Table Creative Biolabs Recent Development
Figure Global Immunotherapy Sales and Growth Rate (2017-2022)
Figure Global Immunotherapy Revenue and Growth Rate (2017-2022)
Table Global Immunotherapy Sales by Regions (2017-2022)
Figure Global Immunotherapy Sales Market Share by Regions in 2021
Table Global Immunotherapy Revenue by Regions (2017-2022)
Figure Global Immunotherapy Revenue Market Share by Regions in 2021
Figure North America Immunotherapy Sales and Growth Rate (2017-2022)
Figure Europe Immunotherapy Sales and Growth Rate (2017-2022)
Figure China Immunotherapy Sales and Growth Rate (2017-2022)
Figure Japan Immunotherapy Sales and Growth Rate (2017-2022)
Figure Southeast Asia Immunotherapy Sales and Growth Rate (2017-2022)
Figure Other Regions Immunotherapy Sales and Growth Rate (2017-2022)
Table Global Immunotherapy Sales by Big Type (2017-2022)
Table Global Immunotherapy Sales Market Share by Big Type (2017-2022)
Figure Global Immunotherapy Sales Market Share by Big Type in 2019
Table Global Immunotherapy Revenue by Big Type (2017-2022)
Table Global Immunotherapy Revenue Market Share by Big Type (2017-2022)
Table Global Immunotherapy Revenue Market Share by Big Type in 2019
Figure Global Monotherapy Sales Growth Rate (2017-2022)
Figure Global Monotherapy Price (2017-2022)
Figure Global Combination Therapy Sales Growth Rate (2017-2022)
Table Global Immunotherapy Sales by Big Application (2017-2022)
Table Global Immunotherapy Sales Market Share by Big Application (2017-2022)
Figure Global Immunotherapy Sales Market Share by Big Application in 2019
Figure Global Hematologic Malignancies Sales Growth Rate (2017-2022)
Figure Global Solid Malignancies Sales Growth Rate (2017-2022)
Figure Global Immunotherapy Sales and Growth Rate (2022-2027)
Figure Global Immunotherapy Revenue and Growth Rate (2022-2027)
Table Global Immunotherapy Sales Forecast by Regions (2022-2027)
Table Global Immunotherapy Market Share Forecast by Regions (2022-2027)
Figure North America Sales Immunotherapy Market Forecast (2022-2027)
Figure Europe Sales Immunotherapy Market Forecast (2022-2027)
Figure China Sales Immunotherapy Market Forecast (2022-2027)
Figure Japan Sales Immunotherapy Market Forecast (2022-2027)
Figure Southeast Asia Sales Immunotherapy Market Forecast (2022-2027)
Figure Other Regions Sales Immunotherapy Market Forecast (2022-2027)
Table Global Immunotherapy Sales Forecast by Type (2022-2027)
Table Global Immunotherapy Market Share Forecast by Type (2022-2027)
Table Global Immunotherapy Sales Forecast by Application (2022-2027)
Table Global Immunotherapy Market Share Forecast by Application (2022-2027)
Table Market Opportunities in Next Few Years
Table Market Risks Analysis
Table Market Drivers
Figure Porter's Five Forces Analysis
Table Macro Analysis of Upstream Markets
Table Key Players in Upstream Markets
Table Key Players of Upstream Markets
Table Key Raw Materials
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Immunotherapy
Table Macro Analysis of Down Markets
Table Key Players in Down Markets
Table Key Players of Downstream Markets
Figure Sales Channel
Figure North America Immunotherapy Sales (K Units) Growth Rate Forecast (2021-2025)
Figure North America Immunotherapy Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure Europe Immunotherapy Sales (K Units) Growth Rate Forecast (2021-2025)
Figure Europe Immunotherapy Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure Japan Immunotherapy Production (K Units) Growth Rate Forecast (2021-2025)
Figure Japan Immunotherapy Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure China Immunotherapy Production (K Units) Growth Rate Forecast (2021-2025)
Figure China Immunotherapy Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure Methodology/Research Approach
Figure Market Size Estimation
Figure Author List
AbbVie
Celgene
Kite Pharma
Oxford BioMedica
Novartis
Gilead
Pfizer
Cellectis
Bellicum
Mustang Bio
CARsgen Therapeutics
Xyphos
Minerva Biotechnologies
Adaptimmune
Ziopharm Oncology
Global Freckle-removing Medical and Beau..
The global market for Freckle-removing Medical and Beauty Eq..
+16467917070US (Toll Free)